L-Carnitine Supplementation Guidelines
Introduction to L-Carnitine
- The general population should not routinely use L-carnitine supplementation for measurable health benefits, as there is insufficient evidence to support its use [1]
Clinical Scenarios for L-Carnitine Use
- L-carnitine may help reduce erythropoietin requirements in dialysis patients with anemia who are unresponsive to standard therapies [2]
- Short-term trials (3-4 months) of L-carnitine may be reasonable for selected dialysis patients with muscle weakness, exercise intolerance, post-dialysis asthenia (fatigue), or intradialytic muscle cramps [2]
- Limited evidence suggests that L-carnitine may improve ejection fraction in some hemodialysis patients [2]
- L-carnitine is essential for the treatment of primary carnitine deficiency, a genetic disorder of the cellular carnitine-transporter system [1]
Prevention of Deficiency
- L-carnitine may be considered for prevention of deficiency in patients on prolonged parenteral nutrition at doses of 0.5-1g/day [1]
Dosage and Administration
- Standard dosing of 0.5-2g/day has a favorable safety profile [4]
- Higher doses (≥3g/day) may cause side effects, including nausea, vomiting, abdominal cramps, diarrhea, "fishy" body odor, muscle weakness in uremic patients, and seizures in those with seizure disorders [1]
Monitoring and Contraindications
- Patients on thyroid medication should have their thyroid function tests monitored 6-8 weeks after starting L-carnitine [4]
- Dialysis patients should be monitored for response to therapy over 3-4 months to determine benefit [2]
- L-carnitine should be avoided in healthy individuals, for lipid management, and as a general supplement for exercise performance [1, 2]
Methodological Limitations
- Many studies on L-carnitine have methodological limitations, including small sample sizes, heterogeneous protocols, and variable assessment methods [2]
- Publication bias may have influenced the available literature, with negative studies less likely to be published [2]
- L-carnitine should be taken at different times than levothyroxine to avoid potential interference with absorption [4]